(Q37324241)

19 August 2017

1 reference

title

Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

B Rubio-Viqueira

1

1 reference

19 August 2017

M Hidalgo

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

12 November 2008

1 reference

Clinical Pharmacology & Therapeutics

19 August 2017

1 reference

19 August 2017

85

1 reference

19 August 2017

217-221

1 reference

19 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2008.200

19 August 2017

0 references

cites work

The price of innovation: new estimates of drug development costs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

The hollow fibre model in cancer drug screening: the NCI experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Phenotypic instability of Saos-2 cells in long-term culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Role of tissue stroma in cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Modulation of tumor cell response to chemotherapy by the organ environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Chemotherapeutic profiles of human tumors implanted in SCID mice showing appreciable inconsistencies with those in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Scaling down imaging: molecular mapping of cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

7 January 2021

An in vivo platform for translational drug development in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

7 January 2021

Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

7 January 2021

Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.200

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.200

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference